Search Results 51-60 of 16716 for GLP-1 agonists

  1. Publications - Kevin J. Renfree, M.D. - Mayo Clinic

    Glucagon-Like Peptide-1 Receptor Agonist Therapy Associated With Fewer Diagnoses of Carpal Tunnel Syndrome Within 2 Years of Treatment. Hand (N Y). 2025 Sep ...

  2. Complex bariatric surgery for high-risk patients and revision of past procedures - Mayo Clinic

    Despite the increased demand for glucagon-like peptide-1 receptor agonists (GLP-1 RAs), surgical procedures will continue to play a vital role in medical weight ...

  3. Manal F. Abdelmalek, M.D. - Mayo Clinic Faculty Profiles

    ... glucagon-like peptide-1 agonists, pan-peroxisome proliferator-activated receptor agonists and fibroblast growth factor-21 agonists. ... One of the challenges ...

  4. Mayo Clinic, Carnegie Mellon researchers secure ARPA-H award for multiyear implantable device research for diabetes and obesity

    Samson has a background in preclinical models and translational research in the use of GLP-1 receptor agonists for metabolic disorders and is the clinical team ...

  5. Mayo Clinic Minute: Using combined therapy to treat obesity INTRO: Research shows that metabolic surgery and GLP-1 medications a

    Page 1. Mayo Clinic Minute: Using combined therapy to treat obesity. INTRO: Research shows that metabolic surgery and GLP-1 medications are both effective ...

  6. A Study To Test The Effect Of BI 456906 On Cardiovascular Safety In People With Overweight Or Obesity (SYNCHRONIZE™ - CVOT) - Mayo Clinic

    ... 1 receptor (GLP-1R) agonists within 3 months before screening. 2. Type 1 diabetes. 3. Less than 3 months between the last dose of GLP-1R agonists and GLP ...

  7. Dr. Adrian Vella Archives - Mayo Clinic News Network

    acarbose). Furthermore, by confining the recommendations to oral medications, another class of injectable medication – glucagon-like peptide-1 receptor agonists ...

  8. Publications - Juan P. Brito Campana, M.B.B.S. - Mayo Clinic

    Thyroid Cancer Risk with GLP-1 Receptor Agonists: Evidence, Knowledge Gaps, and the Path Forward. Thyroid. 2025 Jan; 35 (1):3-5 Epub 2025 Jan 08. View PubMed ...

  9. Use of simultaneous liver transplant and sleeve gastrectomy in managing patients with obesity and end-stage liver disease - Mayo Clinic

    ... glucagon-like peptide-1 (GLP-1) agonists and other medical treatments. For more information. Larson EL, et al. Simultaneous liver transplant and sleeve ...

  10. Publications - Afton Koball, Ph.D., L.P. - Mayo Clinic

    Primary Care Providers Perspectives of GLP-1 Receptor Agonists to Manage Recurrent Weight Gain after Metabolic Bariatric Surgery – a Qualitative Study Obesity ...